Ellen Lubman

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jonathan Owen, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ellen Lubman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Werewolf Therapeutics, Inc. Chief Business Officer Stock Option (right to buy) 131,900 02 Jan 2025 Direct

Insider Reports Filed by Ellen Lubman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HOWL Werewolf Therapeutics, Inc. 02 Jan 2025 1 $0 4 Chief Business Officer 06 Jan 2025, 17:51
HOWL Werewolf Therapeutics, Inc. 02 Jan 2024 1 $0 4 Chief Business Officer 04 Jan 2024, 16:37
HOWL Werewolf Therapeutics, Inc. 03 Jan 2023 1 $0 4 Chief Business Officer 09 Jan 2023, 20:36
HOWL Werewolf Therapeutics, Inc. 06 Jan 2022 1 $0 4 Chief Business Officer 18 Jan 2022, 17:30